Overview

Efficacy and Safety of Egito Association in the Treatment of Type II Diabetes Mellitus and Hypertension (ATENAS)

Status:
Not yet recruiting
Trial end date:
2024-11-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the efficacy and safety of Atenas association in the treatment of type 2 diabetes mellitus and hypertension
Phase:
Phase 3
Details
Lead Sponsor:
EMS
Treatments:
Amlodipine
Empagliflozin
Telmisartan
Telmisartan amlodipine combination